ArticleFrontiers in neurology2022

Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease.

Qian-Ya Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.